Companies: 48,687 Total Market Cap: 127291036954077.85

GE HealthCare Technologies

NASDAQ: GEHC
Healthcare Health Information Services
Rank #636
Market Cap 32.29 B
Volume 7.21 M
Price 70.53
Change (%) 4.23%
Country or region United States United States

GE HealthCare Technologies's latest marketcap:

32.29 B

As of May 4, 2025, GE HealthCare Technologies's market capitalization has reached $32.29 B. According to our data, GE HealthCare Technologies is the 636th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 32.29 B
Revenue (ttm) 19.80 B
Net Income (ttm) 2.18 B
Shares Out 457.88 M
EPS (ttm) 4.76
Forward PE 17.74
Ex-Dividend Date April 25, 2025
Earnings Date April 30, 2025
Market Cap Chart
Data Updated: May 4, 2025

GE HealthCare Technologies's yearly market capitalization.

GE HealthCare Technologies has seen its market value grow from $26.55 B to $30.99 B since 2022, representing a total increase of 16.72% and an annual compound growth rate (CAGR) of 6.85%.
Date Market Cap Change (%)
May 1, 2025 $30.99 B -13.25%
December 31, 2024 $35.72 B 1.47%
December 29, 2023 $35.20 B 32.6%
December 30, 2022 $26.55 B

Company Profile

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. is a global leader in the development, manufacturing, and marketing of innovative medical products, services, and digital solutions. The company specializes in diagnostic, therapeutic, and patient monitoring technologies, serving healthcare providers in the United States, Canada, and internationally.

Business Segments

  • Imaging – Offers advanced imaging solutions, including molecular imaging, CT scanning, MR imaging, X-ray systems, and women’s health products.
  • Advanced Visualization Solutions (AVS) – Provides ultrasound, image-guided therapies, and interventional solutions for disease screening, diagnosis, and treatment.
  • Patient Care Solutions (PCS) – Delivers medical devices, consumables, and digital solutions for patient monitoring, diagnostic cardiology, anesthesia, and maternal care.
  • Pharmaceutical Diagnostics (PDx) – Supplies contrast media and radiopharmaceuticals for enhanced imaging in radiology and nuclear medicine.

Key Offerings

  • Diagnostic imaging systems (CT, MRI, X-ray)
  • Ultrasound and image-guided therapy solutions
  • Patient monitoring and anesthesia products
  • Contrast agents and molecular imaging pharmaceuticals

Company Background

Formerly known as GE Healthcare Holding LLC, the company rebranded as GE HealthCare Technologies Inc. in December 2022. Founded in 2022, it is headquartered in Chicago, Illinois.

Frequently Asked Questions

As of May 4, 2025, GE HealthCare Technologies (including the parent company, if applicable) has an estimated market capitalization of $32.29 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

GE HealthCare Technologies global market capitalization ranking is approximately 636 as of May 4, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 1892
IPO Date n/a
Employees 53,000
CEO Peter Arduini
Sector Healthcare
Industry Health Information Services
Address 500 West Monroe Street
Chicago, Illinois 60661
United States